E09.622 Drug or chemical induced diabetes mellitus with other skin ulcer

Name of the Condition

• Drug or Chemical Induced Diabetes Mellitus with Other Skin Ulcer (ICD-10 Code: E09.622)

Summary

Drug or chemical induced diabetes mellitus with other skin ulcer is a condition where elevated blood sugar levels, caused by exposure to specific medications or chemicals, lead to skin ulceration outside of the foot. This form of diabetes is directly attributable to external factors that disrupt glucose metabolism, resulting in hyperglycemia and associated skin complications.

Causes

The condition is caused by exposure to drugs or chemicals that impair glucose regulation, leading to uncontrolled hyperglycemia and subsequent skin ulceration. Common culprits include medications (e.g., glucocorticoids, antipsychotics, or diuretics) and toxins that reduce insulin secretion or increase insulin resistance. These substances trigger hyperglycemia, which, if untreated, progresses to skin ulcers due to metabolic changes affecting tissue integrity and healing.

Risk Factors

• Use of medications known to affect glucose metabolism (e.g., steroids, antiretrovirals).
• Exposure to chemicals or toxins that disrupt endocrine function.
• Pre-existing metabolic conditions that increase susceptibility to drug-induced effects.
• Dosage and duration of exposure to the causative agent.
• Inadequate management of hyperglycemia.
• Peripheral neuropathy or vascular disease.

Symptoms

• Skin ulceration (non-foot) with slow healing.
• Redness, swelling, or pain at the ulcer site.
• Possible infection or discharge.
• Changes in skin texture or integrity.

Diagnosis

Diagnosis involves confirming hyperglycemia linked to drug or chemical exposure and identifying a non-foot skin ulcer. Clinical evaluation includes assessing the ulcer’s location, size, and characteristics, along with glucose testing. Documentation of the causative agent (e.g., medication history) and exclusion of other diabetes causes is essential. Biopsy or culture may be used to rule out infection or other skin conditions.

Treatment Options

Treatment focuses on managing hyperglycemia (e.g., adjusting or discontinuing the causative agent, initiating glucose-lowering therapy) and promoting ulcer healing (e.g., wound care, infection control). Topical or systemic therapies may address inflammation or infection. Regular monitoring of glucose levels and ulcer progression is critical.

Prognosis and Follow-Up

Prognosis depends on early intervention, glycemic control, and ulcer severity. With proper management, ulcers may heal, but delayed treatment increases complication risk. Follow-up includes regular glucose monitoring, wound assessments, and adjustment of causative agents as needed.

Complications

• Infection (bacterial, fungal, or viral) of the ulcer.
• Delayed healing or chronic ulceration.
• Tissue damage or necrosis.
• Spread of infection to deeper tissues.

Lifestyle & Prevention

• Avoid or minimize exposure to known glucose-disrupting drugs/chemicals when possible.
• Maintain optimal glycemic control through diet, exercise, or medication.
• Practice good skin hygiene and inspect for early signs of ulceration.
• Address underlying metabolic conditions promptly.

When to Seek Professional Help

Seek care if a skin ulcer develops, especially with signs of infection (e.g., redness, pus, fever) or if hyperglycemia symptoms (e.g., excessive thirst, fatigue) occur. Prompt evaluation is critical to prevent complications.

Tips for Medical Coders

Document the specific location of the skin ulcer (non-foot) and confirm the link between hyperglycemia and drug/chemical exposure. Ensure detailed clinical notes support the diagnosis, including the causative agent and ulcer characteristics. Code E09.622 is appropriate when the ulcer is not on the foot and is directly attributable to drug or chemical-induced diabetes.